Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B

Journal of Infection

Volumn 53, Issue 6, 2006, Pages

  Stanzani, Marta ^a   Vianelli, Nicola ^a   Bandini, Giuseppe ^a   Paolini, Stefania ^a   Arpinati, Mario ^a   Bonifazi, Francesca ^a   Giannini, Benedetta ^a   Agostinelli, Claudio ^a   Baccarani, Michele ^a   Ricci, Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antifungal therapy; Disseminated Fusariosis; Stem cell transplantation

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CARMUSTINE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; PIPERACILLIN PLUS TAZOBACTAM; THYMOCYTE ANTIBODY; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD CULTURE; CASE REPORT; DISEASE SEVERITY; DRUG RESPONSE; FUNGUS HYPHAE; FUSARIUM SOLANI; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LEUKEMIA REMISSION; LUNG MYCOSIS; MALE; MYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; SKIN BIOPSY; SKIN NODULE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; FUSARIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MYCOSES; PYRIMIDINES; TRIAZOLES;

EID: 33750605303     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.02.011     Document Type: Article

References (10)

1. Fleming R.V., Walsh T.J., and Anaissie E.J. Emerging and less common fungal pathogens. Infect Dis Clin North Am 16 (2002) 915-934
2. Nucci M., Marr K.A., Queiroz-Telles F., Martins C.A., Trabasso P., Costa S., et al. Fusarium infection in hematopoietic stem cell transplant recipient. Clin Infect Dis (2004) 1237-1242
3. Spyridonidis A., Bertz H., Ihorst G., Grüllich C., and Finke J. Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (≥60 years) with acute myeloid malignancies. Blood 105 10 (2005) 4147-4148
4. Nucci M., and Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised host: implications for diagnosis and management. Clin Infect Dis 35 (2002) 909-920
5. Bodey G.P., Boktour M., Mays S., Duvic M., Kontoyiannis D., Hachem R., et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 47 (2002) 659-666
6. Boutali E.I., and Anaissie E.J. Fusarium, a significant emerging pathogen in patients with hematological malignancy: ten years experience at a cancer center and implications for management. Blood 90 (1997) 999-1008
7. Nucci M., Anaissie E.J., Queiroz-Telles F., Martins C., Trabasso P., Solza C., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98 (2003) 315-319
8. Consigny S., Dhedin N., Datry A., Choquet S., Leblond V., and Chosidow O. Successful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient. Clin Infect Dis 37 (2003) 311-313
9. Perfect J.R., Marr K.A., Walsh T.J., Greenberg R.N., DuPont B., de la Torre-Cisneros J., et al. Voriconazole treatment for less-common, emerging, or refractory fungal infection. Clin Infect Dis 36 (2003) 1122-1131
10. Rodriguez C.A., Lujan-Zibermann J., Woodard P., Andreansky M., and Adderson E.E. Successful voriconazole treatment of disseminated fusariosis. Bone Marrow Transplant 31 (2003) 411-412